IRIS
DIPASQUALE, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.159
NA - Nord America 3.096
AS - Asia 2.160
SA - Sud America 685
AF - Africa 63
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.993
RU - Federazione Russa 2.224
SG - Singapore 886
BR - Brasile 573
CN - Cina 556
IE - Irlanda 510
IT - Italia 413
SE - Svezia 407
HK - Hong Kong 240
VN - Vietnam 148
DE - Germania 145
FR - Francia 107
PL - Polonia 103
IN - India 88
GB - Regno Unito 69
FI - Finlandia 49
MX - Messico 43
TR - Turchia 42
CA - Canada 37
ID - Indonesia 31
BD - Bangladesh 30
IQ - Iraq 29
AR - Argentina 26
AT - Austria 25
NL - Olanda 22
UZ - Uzbekistan 21
ZA - Sudafrica 21
CO - Colombia 20
EC - Ecuador 19
ES - Italia 17
JP - Giappone 16
UA - Ucraina 15
VE - Venezuela 15
CL - Cile 11
LT - Lituania 11
MA - Marocco 10
PK - Pakistan 10
CR - Costa Rica 8
NP - Nepal 7
PH - Filippine 7
TN - Tunisia 7
KE - Kenya 6
PY - Paraguay 6
SA - Arabia Saudita 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
MY - Malesia 5
PE - Perù 5
BE - Belgio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
MK - Macedonia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CI - Costa d'Avorio 3
CY - Cipro 3
EE - Estonia 3
LV - Lettonia 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
IR - Iran 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
Totale 10.162
Salva come PNG Salva come JPEG
Città #
Ashburn 679
Moscow 612
Dublin 483
Singapore 458
Chandler 342
Dallas 289
Hong Kong 238
Nyköping 201
Messina 193
Beijing 165
San Jose 160
The Dalles 100
Warsaw 100
Princeton 83
Los Angeles 79
Lauterbourg 61
Munich 60
New York 57
São Paulo 50
Medford 49
Dearborn 46
Des Moines 46
Council Bluffs 44
Ho Chi Minh City 40
Hanoi 37
Guangzhou 36
Menlo Park 34
Redondo Beach 34
Jacksonville 31
Orem 30
Buffalo 25
Tianjin 25
Seattle 22
Chennai 21
Frankfurt am Main 21
Santa Clara 21
Turku 21
Vienna 21
Istanbul 20
Brooklyn 17
Nanjing 17
Reggio Calabria 17
Tashkent 17
Amsterdam 16
Belo Horizonte 16
Boardman 16
Ann Arbor 15
Chicago 15
Denver 15
Jakarta 15
Jinan 15
Helsinki 14
London 14
Mexico City 14
Palermo 14
Hyderabad 13
Baghdad 12
Hangzhou 12
Johannesburg 12
Nuremberg 12
Rio de Janeiro 12
Rome 12
Tokyo 12
Wilmington 12
Lappeenranta 11
Manchester 11
Milan 11
Brasília 10
Curitiba 10
Dong Ket 10
Düsseldorf 10
Madrid 10
Montreal 10
Phoenix 10
Caltagirone 9
Stockholm 9
Taizhou 9
Bogotá 8
Cambridge 8
Caracas 8
Catania 8
Guayaquil 8
Bremen 7
Da Nang 7
Fortaleza 7
Mumbai 7
Piracicaba 7
Pune 7
Shenyang 7
Boston 6
Ningbo 6
Quito 6
San Francisco 6
San José 6
San Mateo 6
Toronto 6
Zhengzhou 6
Ankara 5
Baku 5
Bologna 5
Totale 5.672
Salva come PNG Salva come JPEG
Nome #
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 234
Acute Malnutrition in Children: Pathophysiology, Clinical Effects and Treatment 206
Biallelic Variants in KIF17 Associated with Microphthalmia and Coloboma Spectrum 204
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 194
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 190
Inflammatory biomarkers and intellectual disability in patients with Down syndrome 177
Headache and diplopia after rapid maxillary expansion: a clue to underdiagnosed pseudotumor cerebri syndrome? 175
Standard polymeric formula tube feeding in neurologically impaired children: A five-year retrospective study 171
Appropriate age at solid introduction: is EFSA extending the individualised window on a sounding scientific evidence? 170
Managing Pediatric Foreign Body Ingestions: A 10-Year Experience 170
Efficacy, safety, and pharmacokinetics of anti-TNF-α biosimilars in pediatric patients with inflammatory bowel diseases 169
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 164
Breastfeeding and IL-10 levels in children affected by cow's milk protein allergy: A restrospective study 164
A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function 161
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases, Valeria Dipasquale, Marco Atteritano, Irene Castagna, Jlenia Fresta, Giovanni Conti 161
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition 158
Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases 157
Prominent and regressive brain developmental disorders associated with nance-horan syndrome 155
Pericarditis during infliximab therapy in paediatric ulcerative colitis 153
Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein 151
Antiemetic Drug Use in Children: What the Clinician Needs to Know 150
An overview of the clinical management of cyclic vomiting syndrome in childhood 150
Update on the classification and pathophysiological mechanisms of pediatric cardiorenal syndromes 150
Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety 149
Laparoscopic robotic-assisted restorative proctocolectomy and ileal J-pouch-anorectal anastomosis in children 149
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 145
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network 144
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 143
Cutaneous small-vessel vasculitis associated with paediatric ulcerative colitis: A case study and literature review 143
Complementary feeding: new styles versus old myths 143
Vaccination strategies in pediatric inflammatory bowel disease 141
Colectomy and health-related quality of life in children with ulcerative colitis 141
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications 138
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population 136
Thalidomide for de novo Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis 135
The management of colonic polyps in children: a 13-year retrospective study 134
Clinical features and long-term outcomes in pediatric cyclic vomiting syndrome: A 9-year experience at three tertiary academic centers 134
Gastrointestinal symptoms in children: Primary care and specialist interface 133
Health-Related Quality of Life and Home Enteral Nutrition in Children with Neurological Impairment: Report from a Multicenter Survey 133
Pancreatic associated manifestations in pediatric inflammatory bowel diseases 133
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 132
Vaccinations and Immune Response in Celiac Disease 131
Diet and nutrition in pediatric inflammatory bowel diseases 131
Illegal immigration: The puzzling role of several risk factors for rhabdomyolysis 130
Surgery-related quality of life of pediatric patients with Crohn's disease 130
Spontaneous reporting of adverse reactions related to proton pump inhibitors 127
Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis 123
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 121
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 117
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 116
Nutrition in pediatric gastroenterology 115
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 114
Duodenal Duplication Cysts in Children: Clinical Features and Current Treatment Choices 114
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 113
A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice 111
Clinical Course of Very Early-Onset Inflammatory Bowel Disease 110
Risk Factors for Complications and Disease Recurrence after Ileocecal Resection for Crohn’s Disease in Children and Adults 107
Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN 106
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease 105
Enhanced Recovery Care versus Traditional Care after Surgery in Pediatric Patients with Inflammatory Bowel Disease: A Retrospective Case-Control Study 98
Gastrointestinal and nutritional issues in children with neurological disability 97
Premenstrual asthma: A myth or a reality? 96
Management of Gastrointestinal and Nutritional Problems in Children with Neurological Impairment: A Survey of Practice 94
Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease 94
Early Tube Feeding Improves Nutritional Outcomes in Children with Neurological Disabilities: A Retrospective Cohort Study 92
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 92
Bowel preparation and factors correlated with patients and parents 90
Octreotide: A Therapeutic Option for Pediatric Pseudotumor Cerebri Syndrome? 89
Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders 85
Real food in enteral nutrition for chronically ill children: overview and practical clinical cases 79
Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition 77
Top-ten tips for managing nutritional issues and gastrointestinal symptoms in children with neurological impairment 77
null 76
Standard and Specialized Infant Formulas in Europe: Making, Marketing, and Health Outcomes 71
Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases 69
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group 65
De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN 61
Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease 56
New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative Review 55
Vitamin D in Prevention of Autoimmune Diseases 44
Different Vitamin D Supplementation Strategies in the First Years of Life: A Systematic Review 43
Genes vs environment in inflammatory bowel disease: an update 29
Gastrointestinal and nutritional care in pediatric neuromuscular disorders 25
Malnutrition management in children with chronic kidney disease 22
Tube Feeding in Neurologically Disabled Children: Hot Topics and New Directions 21
Kono-S Anastomosis in Pediatric Crohn’s Disease: Experience at a Tertiary Referral Center 18
Does the SCOPE (Sclerosing Cholangitis Outcomes in PEdiatrics) index effectively predict later liver transplantation in children with sclerosing cholangitis? 17
Infliximab biosimilar GP1111: a review of 5 years’ post-approval experience 13
Refeeding syndrome in pediatric age, an unknown disease: A narrative review 13
Eosinophilic esophagitis in children and adolescents: a clinical practice guideline 2
Long‐term safety and durability of multiple anti‐TNFα switches in pediatric inflammatorybowel disease: A SIGENP multicenter study 1
Totale 10.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022709 2 30 8 210 53 1 25 17 34 109 39 181
2022/20231.351 100 141 54 79 74 140 22 100 577 8 34 22
2023/2024333 23 60 23 30 21 53 14 46 1 23 4 35
2024/20251.888 25 47 38 169 92 74 61 301 408 165 181 327
2025/20265.555 318 333 369 353 497 1.044 640 739 734 292 120 116
Totale 10.422